BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23077602)

  • 21. The role of circulating tumor cells in evaluation of prognosis and treatment response in advanced non-small-cell lung cancer.
    Zhou J; Dong F; Cui F; Xu R; Tang X
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):825-833. PubMed ID: 28289866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay.
    Li Q; Qi H; Zhou HX; Deng CY; Zhu H; Li JF; Wang XL; Li FR
    Int J Nanomedicine; 2011; 6():2175-81. PubMed ID: 22114481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor endothelial markers define novel subsets of cancer-specific circulating endothelial cells associated with antitumor efficacy.
    Mehran R; Nilsson M; Khajavi M; Du Z; Cascone T; Wu HK; Cortes A; Xu L; Zurita A; Schier R; Riedel B; El-Zein R; Heymach JV
    Cancer Res; 2014 May; 74(10):2731-41. PubMed ID: 24626092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating endothelial and endothelial progenitor cells in non-small-cell lung cancer.
    Fleitas T; Martínez-Sales V; Gómez-Codina J; Martín M; Reynés G
    Clin Transl Oncol; 2010 Aug; 12(8):521-5. PubMed ID: 20709649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluid biopsy for circulating tumor cell identification in patients with early-and late-stage non-small cell lung cancer: a glimpse into lung cancer biology.
    Wendel M; Bazhenova L; Boshuizen R; Kolatkar A; Honnatti M; Cho EH; Marrinucci D; Sandhu A; Perricone A; Thistlethwaite P; Bethel K; Nieva J; Heuvel Mv; Kuhn P
    Phys Biol; 2012 Feb; 9(1):016005. PubMed ID: 22307026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
    Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
    Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effects of Different Surgical Approaches on the Perioperative Level of Circulating Tumor Cells in Patients with Non-Small Cell Lung Cancer.
    Huang HB; Ge MJ
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):515-9. PubMed ID: 26030121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating Biomarkers in Non-Small-Cell Lung Cancer: Current Status and Future Challenges.
    Matikas A; Syrigos KN; Agelaki S
    Clin Lung Cancer; 2016 Nov; 17(6):507-516. PubMed ID: 27373516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Circulating endothelial cells in the peripheral blood of advanced NSCLC patients].
    Huang C; Li K; Wei XY; Niu RF; Sun Y; Wang JW; Zhu YZ; Xu LY; Liu XQ; Gao HJ; Zhou JM; Wang XW
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):780-3. PubMed ID: 17366796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
    Chen X; Wang X; He H; Liu Z; Hu JF; Li W
    PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer.
    Shibata Y; Kobayashi N; Sato T; Nakashima K; Kaneko T
    Thorac Cancer; 2020 May; 11(5):1258-1264. PubMed ID: 32163231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study.
    Yamashita J; Matsuo A; Kurusu Y; Saishoji T; Hayashi N; Ogawa M
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):299-305. PubMed ID: 12167790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating small-sized endothelial microparticles as predictors of clinical outcome after chemotherapy for breast cancer: an exploratory analysis.
    García Garre E; Luengo Gil G; Montoro García S; Gonzalez Billalabeitia E; Zafra Poves M; García Martinez E; Roldán Schilling V; Navarro Manzano E; Ivars Rubio A; Lip GYH; Ayala de la Peña F
    Breast Cancer Res Treat; 2018 May; 169(1):83-92. PubMed ID: 29340882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Circulating endothelial microparticles for prediction of therapeutic effect in advanced lung cancer].
    Liu TT; Wang J; Cui PF; Li T; Hou BC; Zhang SJ; Hu Y
    Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):723-728. PubMed ID: 32988153
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.
    Ilie M; Long E; Hofman V; Selva E; Bonnetaud C; Boyer J; Vénissac N; Sanfiorenzo C; Ferrua B; Marquette CH; Mouroux J; Hofman P
    Br J Cancer; 2014 Mar; 110(5):1236-43. PubMed ID: 24473396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumor cells count as a predictor of survival in lung cancer.
    Syrigos K; Fiste O; Charpidou A; Grapsa D
    Crit Rev Oncol Hematol; 2018 May; 125():60-68. PubMed ID: 29650278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single tube liquid biopsy for advanced non-small cell lung cancer.
    de Wit S; Rossi E; Weber S; Tamminga M; Manicone M; Swennenhuis JF; Groothuis-Oudshoorn CGM; Vidotto R; Facchinetti A; Zeune LL; Schuuring E; Zamarchi R; Hiltermann TJN; Speicher MR; Heitzer E; Terstappen LWMM; Groen HJM
    Int J Cancer; 2019 Jun; 144(12):3127-3137. PubMed ID: 30536653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic roles of circulating ALDH1
    Tian S; Xing YN; Xia P
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30305380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.